Kalvista Pharmaceuticals Valuation
| KALV Stock | USD 10.09 0.11 1.10% |
At this time, the firm appears to be undervalued. Kalvista Pharmaceuticals secures a last-minute Real Value of $12.56 per share. The latest price of the firm is $10.09. Our model forecasts the value of Kalvista Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of -0.91, shares owned by insiders of 1.34 %, and Current Valuation of 328.56 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Kalvista Pharmaceuticals' valuation include:
Price Book 2.8738 | Enterprise Value 328.6 M | Enterprise Value Ebitda (3.53) | Price Sales 107.4168 | Enterprise Value Revenue 76.3323 |
Undervalued
Today
Please note that Kalvista Pharmaceuticals' price fluctuation is somewhat reliable at this time. Calculation of the real value of Kalvista Pharmaceuticals is based on 3 months time horizon. Increasing Kalvista Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Kalvista stock is determined by what a typical buyer is willing to pay for full or partial control of Kalvista Pharmaceuticals. Since Kalvista Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kalvista Stock. However, Kalvista Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.09 | Real 12.56 | Target 20.67 | Hype 10.2 |
The intrinsic value of Kalvista Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kalvista Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kalvista Pharmaceuticals helps investors to forecast how Kalvista stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kalvista Pharmaceuticals more accurately as focusing exclusively on Kalvista Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kalvista Pharmaceuticals' intrinsic value based on its ongoing forecasts of Kalvista Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kalvista Pharmaceuticals' closest peers.
Kalvista Pharmaceuticals Cash |
|
Kalvista Valuation Trend
Analysing the historical paterns of Kalvista Pharmaceuticals' enterprise value and its market capitalization is a good way to estimate and gauge the value of Kalvista Pharmaceuticals over time and is usually enough for investors to make rational market timing decisions.
Kalvista Pharmaceuticals Total Value Analysis
Kalvista Pharmaceuticals is now expected to have valuation of 328.56 M with market capitalization of 496.58 M, debt of 7.32 M, and cash on hands of 142.08 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Kalvista Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
328.56 M | 496.58 M | 7.32 M | 142.08 M |
Kalvista Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Kalvista is to check how much profit was generated for every dollar of assets it reports. Kalvista Pharmaceuticals secures a negative usage of assets of -0.54 %, losing $0.005394 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Kalvista Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Kalvista Pharmaceuticals Ownership Allocation
The majority of Kalvista Pharmaceuticals outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Kalvista Pharmaceuticals to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Kalvista Pharmaceuticals. Please pay attention to any change in the institutional holdings of Kalvista Pharmaceuticals as this could imply that something significant has changed or is about to change at the company.Kalvista Pharmaceuticals Profitability Analysis
Net Loss for the year was (126.64 M) with loss before overhead, payroll, taxes, and interest of (80.28 M).About Kalvista Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Kalvista Pharmaceuticals. We calculate exposure to Kalvista Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kalvista Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -86.2 M | 29 K | |
| Pretax Profit Margin | (3.60) | (3.79) | |
| Operating Profit Margin | (4.04) | (4.24) | |
| Net Loss | (3.60) | (3.79) | |
| Gross Profit Margin | 1.14 | 1.09 |
Kalvista Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Kalvista Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 36.8 M |
Kalvista Pharmaceuticals Current Valuation Indicators
Kalvista Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Kalvista Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kalvista Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kalvista Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kalvista Pharmaceuticals' worth.Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.